Research & Development
Pathology & AI
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
The test provides early detection for infants with homocystinuria, an inherited disease that causes serious complications if left untreated.
March 16, 2023
Amplified Sciences developing dye-based tests for early detection of pancreatic cancer
Tests under development by the Purdue Research Foundation-affiliated startup use dyes to identify the potential for malignancy in fluid extracted from a cyst on the pancreas.
March 15, 2023
Noze nabs $1M grant from Bill & Melinda Gates Foundation to develop breath testing platform
The aim is to develop a platform that enables rapid screening and diagnostic testing for infectious diseases such as malaria and tuberculosis that impact millions of people, particularly in developing countries, Noze said.
March 14, 2023
Servier, Qiagen partner to develop companion diagnostic test for AML
Under a master collaboration agreement, Qiagen will develop and validate a real-time PCR-based in vitro diagnostic test that can be used to detect IDH1 gene mutations in whole blood and bone marrow aspirates in AML.
March 9, 2023
AriBio, Fujirebio partner on biomarker development for Alzheimer’s, other neurodegenerative disorders
The agreement will provide Fujirebio access to clinical samples and data that have been collected in an ongoing phase III Alzheimer’s disease study being conducted by AriBio.
March 8, 2023
Protein expression biomarker may identify likely responders to potential breast cancer drug
In a study, researchers sought to understand the value of RANK and RANKL protein expression as a predictor of breast cancer outcomes and as a therapeutic target.
March 8, 2023
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
Patients prefer immediate test results, even when the news is bad
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
ApoB testing may reveal patients at risk of heart disease missed by cholesterol tests: study
In the study, investigators looked at electronic medical records for patients who had ApoB and standard lipid profiles tested within 90 days of each other from 2010 to early 2022.
March 6, 2023
Improved gut-on-chip devices spur research into how the microbiome affects human health
Organ-on-a-chip devices have the potential to bridge the gap between lab models and human biology but the unique environmental conditions found in the gut have held back their deployment.
February 28, 2023
Beckman Coulter, Sciex collaborate on high-throughput screening workflows
The Sciex Echo MS system, which leverages acoustic ejection mass spectrometry, is now compatible with the Biomek and Echo liquid handler lines from Beckman Coulter Life Sciences.
February 27, 2023
Prototype sweat sensor developed to detect medical conditions
Human sweat comes in different forms which contain biomarkers that could assist doctors in making health diagnoses.
February 27, 2023
Brown University researchers developing serum-based tool for antidepressant monitoring
The technique simplifies and automates the monitoring of antidepressant drugs in human serum samples, addressing a biomedical need. The method has the potential to be translated to clinical settings, the authors wrote.
February 14, 2023
UnitedHealthcare to offer coverage for Foundation Medicine CDx tests for multiple cancer types
Both tests can be used to identify patients who may benefit for treatment from specific targeted therapies. UnitedHealthcare’s coverage for the tests will be effective beginning April 1, 2023.
February 9, 2023
Page 1 of 43